Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Aehr Test Systems (AEHR) has filed a Form 144, indicating a proposed sale of 18,000 common shares through Fidelity Brokerage Services. The shares have an aggregate market value of $356,972.22 and represent roughly 0.06% of the 29.77 million shares outstanding. The filer plans to execute the sale on or about 07/22/2025. The shares were acquired via an employee stock option granted on 08/17/2018 and are to be paid for in cash upon exercise. No other sales by the filer were reported during the past three months.
The notice contains no earnings data or operational updates; it simply alerts the market to a small potential insider transaction. Given the limited size relative to the company’s float, the filing is unlikely to be material to AEHR’s valuation or liquidity.
Aehr Test Systems (ticker AEHR) has filed a Form 144 indicating a planned sale of 3,000 common shares through Fidelity Brokerage Services on 15 July 2025. The proposed sale represents approximately 0.01 % of the company’s 29,771,410 shares outstanding and carries an aggregate market value of $42,390.
The shares to be sold were acquired via seven separate restricted-stock vesting events between 18 January 2024 and 11 January 2025, totaling exactly the 3,000 shares being registered. The filer reports no other sales in the past three months and affirms awareness of no undisclosed material adverse information about the company, in line with Rule 144 requirements.
Given the small size of the transaction relative to float and its origin from routine equity compensation, the filing is unlikely to be financially material for most investors, but it does add a data point to insider-trading dashboards.